NeoStem (AMEX:NBS), an international biopharmaceutical company focused on cell-based therapies, said on Tuesday that it has rescheduled its presentation at the 6th Annual JMP Securities healthcare conference.
Chairman and CEO Robin Smith of NeoStem and Chief Medical Officer Andrew Pecora said they will present today at 3:30 p.m. at the St. Regis Hotel in New York City.
NeoStem, with operations in China and the US, is focused on developing cellular therapies and becoming a source for the collection, storage, manufacturing and transportation of stem cells. It also has a 51% interest in a Chinese generic pharmaceutical manufacturing company.
Proactiveinvestors is a leading multi-media news organisation, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt and London.
No comments:
Post a Comment